Replies to post #42653 on RespireRx Pharmaceuticals Inc (RSPI)

[sav79]

I think that's what we'll have here. The recent source of funding, Primary Capital, is experienced in OTC funding.

The guy who runs Primary knows the OTC game and assuming they see the potential for the drug, they'll be willing to fund the clinical trials and run the stock accordingly. The opportunity won't be wasted.

John Leo (Primary Capital LLC):

From 1996 through 2001, Mr. Leo worked as a market maker trading Pink Sheet, Over-The-Counter and NASDAQ-listed securities as well as IPOs. He was a registered securities principal and OTC trader with AM Capital and M.H. Meyerson. At these firms, Mr. Leo was responsible for executing orders for non-market makers as well as position trading for the firms’ proprietary accounts. While at M.H. Meyerson, between 1997 and 2001, Mr. Leo managed a profitable trading list of three hundred securities. Mr. Leo traded long and short positions, used technical analysis and hedging techniques, along with short-term charting trends to make investment decisions.